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Is the fetal thyroid already capable to increase its iodide up-
take in response to iodine deficiency? To answer this question,
we analyzed the expression of the Na/I symporter and sev-
eral other genes in the thyroid of rat fetuses at 21 d of gestation
from control mothers presenting a mild or more severe iodine
deficiency. Female rats were placed on a low iodine diet, not
supplemented, or supplemented with iodide or perchlorate
for 3 months. The maternal and fetal thyroidal iodide uptake
was measured 24 h after injection of 10 Ci Na 125I into the
dams. The absolute iodide uptake of the maternal thyroid was
unchanged in a low iodine diet, not supplemented, compared
with one supplemented with iodide. In contrast, the fetal thy-
roid absolute iodide uptake of a low iodine diet, not supple-
mented, and one supplemented with perchlorate was de-
creased by 70% and 95% compared with that supplemented
with iodide. Na/I symporter mRNA was detected in the fetal
thyroid of supplemented with iodide and increased about 2-
and 4- fold in the thyroid of fetuses from a low iodine diet, not
supplemented, and one supplemented with perchlorate, re-
spectively. Na/I symporter expression was induced in the
fetal side of the placenta in both a low iodine diet, not sup-
plemented, and one supplemented with perchlorate; in con-
trast, Na/I symporter mRNA was never detected in the ma-
ternal side of the placenta. Fetal thyroid thyroglobulin and
type I deiodinase mRNA contents were only significantly in-
creased with a diet supplemented with perchlorate. Glucose
transporter 4 mRNA was decreased in the fetal thyroid of both
a low iodine diet, not supplemented, and one supplemented
with perchlorate compared with one supplemented with
iodide.
In conclusion, although the up-regulation of Na/I sym-
porter expression in fetal thyroid and placenta in the low
iodine diet, not supplemented group did not lead to restora-
tion of a normal absolute iodide uptake, our data show that all
adaptive and/or defending mechanisms against iodine defi-
ciency are already present in the fetus. (Endocrinology 142:
3736–3741, 2001)
THE UPTAKE OF iodide is an essential step in thyroidhormone synthesis. This transport process is mediated
by the Na/I symporter (NIS). Before the identification of
NIS, the iodide transport process had already been charac-
terized, being energy, temperature, sodium, and, above all,
TSH dependent (1). The rat NIS cDNA has been cloned by
Dai et al. (2), followed in the same year by the cloning of the
human NIS (3). Antibodies directed against the C-terminal
part of the protein had been used to characterize the molec-
ular forms of rat NIS and to analyze the distribution of the
protein in the rat thyroid and in FRTL-5 cells (4, 5). NIS
mRNA and protein levels of FRTL-5 cells increase in re-
sponse to TSH, whereas TGF-1, TNF- suppress the TSH-
induced increase of NIS expression (6, 7). Alterations of the
structure and/or expression of the NIS gene are implicated
in various thyroid disorders: congenital hypothyroidism (8,
9), autoimmunity (10, 11), treatment of cancer (12, 13), and
iodine deficiency (14). In a recent report, it has been sug-
gested that a decrease in NIS expression might play a role in
the escape from the acute Wolff-Chaikoff effect (15).
Iodine deficiency induces goiter formation and several
thyroidal changes that contribute to increase the efficiency of
the synthesis of thyroid hormones (16, 17). Despite adaptive
mechanisms, there are changes in circulating thyroid hor-
mone levels. Mild iodine deficiency in rats is characterized
by a lowered plasma T4 concentration, a normal T3 concen-
tration, and normal to slightly elevated TSH levels. In mod-
erately severe iodine deficiency, very low T4, normal or low-
ered T3, and elevated TSH levels are found (16–24) and
thyroids are enlarged. During mild iodine deficiency, the
absolute iodide uptake (AIU) of the thyroid of pregnant rats
is not changed, but that of the fetal thyroid is decreased (25).
Thyroid hormones are essential during fetal development,
especially for the brain (26–28). Fetal brain development is
especially dependent on the maternal supply of T4 before its
own thyroid starts to function (at d 17.5) (29, 30). After the
onset of the fetal thyroid function, a large part of circulating
T4 is also coming from the mother (31, 32). Not much T3 is
transferred from the mother to the fetus (31). When iodine
intake is low, less thyroid hormones are synthesized by the
maternal thyroid, and, as a consequence, during pregnancy
there will be less T4 available from the mother for the fetus
(24, 28, 30).
This study was undertaken to determine whether NIS
Abbreviations: AIN, American Institute of Nutrition; AIU, absolute
iodide uptake; BAT, brown adipose tissue; D1, deiodinase type 1; MID,
mild iodine diet; NIS, Na/I symporter; PII, plasma inorganic iodide;
Tg, thyroglobulin.
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expression is modified in the fetal thyroid, when the mother
is exposed to iodine deficiency. To study this, the effect of
different levels of iodine deficiency of the mother on the
expression of the NIS and other genes, in fetal tissues of the
rat, was investigated. The fetuses were obtained from preg-
nant rats at 21 d of gestation. We analyzed in the fetal thy-
roids NIS, glucose transporters (Glut1 and Glut4), iodothy-
ronine deiodinase type 1 (D1), and thyroglobulin (Tg) mRNA
expression. Maternal and fetal thyroidal iodide uptake was
measured 24 h after administration of 10 Ci Na125I to the
dams. We describe clear changes in the rat fetal thyroids in




The experiments were approved by the Local Committee on Animal
Care. Three groups of rats (CPB/WU, Iffa Credo, Brussels, Belgium)
were used (body weight, 210  5 g). The rats (n  6 per group) were
housed at 22 C, with alternating 14-h light and 10-h dark periods. They
were fed the American Institute of Nutrition (AIN) diet (33), without
iodide [mild iodine diet (MID)]. In one group potassium perchlorate
(0.005%) was added to this diet (MIDP), and in the third group po-
tassium iodide (1.5 g per day) was added to the diet (MIDI). This last
group served as controls (24). After 3 months rats were mated, and the
morning that sperm was present was taken as day zero of pregnancy.
Rats were housed in metabolic cages for 5 d. This allowed us to collect
urine over 24-h periods of time and to measure the iodine excretion
according to Sandell and Kolthoff (34). At d 21 of pregnancy, rats were
bled and perfused under light ether anesthesia. Fetal tissues (brown
adipose tissue, brain, liver, skin, thyroid, fetal and maternal placenta,
skin) were taken, and kept frozen at70 C until used. The skin was taken
from the rump, excluding that of the head, legs, and tail. The fetal and
maternal (basal) sides of the placenta were isolated by separation of the
two distinct layers from each other with blunt forceps on ice (24). At d
21 of pregnancy fetal and maternal iodine uptake was measured as
described previously (25). Dams received an ip injection of 10Ci Na125I
at day 20, and were placed in metabolic cages for collection of urine.
After 24 h rats were bled and perfused under light ether anesthesia. The
maternal and fetal thyroids were dissected, counted, and the measured
radioactivities were expressed as percentages of the injected dose.
Plasma inorganic iodide (PII) and AIU were calculated from the values
of the thyroid radioiodide content (percentage of the dose) and the
specific activity of the maternal urinary iodide (25).
Determinations of plasma TSH, T3, and T4 in plasma
Plasma T4 and T3 concentrations were assayed by rat-specific RIAs
(35). Plasma TSH was measured using the RIA developed for rat TSH
by the NIDDK (NIH, Bethesda, MD). Reference preparation-2 was used
as a standard.
Northern blot analysis of NIS, Tg, D1, Glut1, and Glut4
mRNA levels
Total RNA was extracted with guanidine-HCl as described previ-
ously (36), using ethanol precipitation. From each experimental group
three dams were used for the fetal tissues. Four to five fetal thyroids were
pooled. Total recovery of RNA was 50–150 g. Total RNA (20–25 g)
was denatured and subjected to electrophoresis on a 2.2-m formalde-
hyde 1% agarose gel in 1 MOPS buffer and transferred to nylon
membranes (Nytran, NY13N) (36). A NIS cDNA fragment (5: 561/3:
1333) of 773 bp obtained by RT-PCR from FRTL-5 mRNA, Glut 1, and
4 cDNA (provided by Dr. G. Bell, Howard Hughes Medical Institute and
Department of Biochemistry and Molecular Biology and Medical Uni-
versity of Chicago, Chicago, IL), Tg cDNA (provided by Dr. R. Di Lauro,
Stazione Zoologica, Anton DOHRN, Naples, Italy), and rat D1 cDNA
(provided by Dr. P. R. Larsen, Brigham & Women’s Hospital, Boston,
MA) were used as probes. The cDNA probes were labeled with
[-32P]deoxy-CTP using random primers. The filters were hybridized
overnight at 42 C, and autoradiographs were made. They were scanned
with an Instant Imager (Packard, Downers, Grove, IL) and quantified
using the software packet Instant Quant (Packard). The 18S ribosomal
RNA or cyclophilin mRNA were used to correct for differences of RNA
loading.
Statistics
Values are given as the mean  sem. Statistical analysis was per-
formed by ANOVA (37), and differences between mean values were
considered significant at P less than 0.05.
Results
The experimental set-up chosen provided three distinct
levels of iodine intake: a normal iodide intake (MIDI),
intermediate (MID), and low iodide intake (MIDP). The
daily urinary iodide excretion was: 1.62  0.08 g (MIDI);
0.42 0.04 g (MID); 0.60 0.05 g (MIDP). The excretion
of iodide in MIDP was higher than that in MID due to the
higher PII, because the uptake of I, not only from the diet but
also from thyroid hormone metabolism, was blocked by P,
whereas in MID rats part of this iodide can be reused for
thyroid hormone synthesis. The maternal body weight (at d
21, 321  6 g), the number and weight of fetuses were not
altered in MID and MIDP (data not shown). The maternal
thyroids were significantly enlarged in MIDP (58.0  5.5
mg) compared with those of MIDI (21.0 4.2 mg) and MID
(27.2  2.4 mg).
T4, T3, and TSH concentrations in maternal and fetal
plasma are reported in Fig. 1. Maternal plasma T4 was de-
creased by 40% in the MID group and was close to the
detection limit (1.5 nmol/liter) in the MIDP group.
Plasma T3 concentrations did not change. Plasma TSH con-
centration was slightly (however, not significantly) elevated
in MID and increased 10 times in MIDP. Changes in the
fetal plasma were comparable with those found for the dams:
a decrease in T4 concentration, unchanged plasma T3 con-
centration, and a marked increase in plasma TSH in MIDP.
The 24-h AIU of the maternal thyroid was similar in MID
and MIDI (Fig. 2), but was very low in MIDP. In contrast,
FIG. 1. Changes in T4 (nmol/liter), T3 (nmol/liter), and TSH (ng/ml)
concentrations in maternal and fetal plasma at 21 d of gestation in
MIDI (n 6), MID (n 6), and MIDP (n 6). Plasma of the fetuses
was pooled per dam. Values are mean  SEM. *, P  0.05 vs. MIDI.
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the fetal AIU (that is the amount of iodide derived from the
maternal circulation) decreased by about 65% (from 70 to 24
ng/24 h) in MID and decreased even more in MIDP (about
93%). The PII concentration in the dams and fetuses was only
decreased in MID.
Figure 3 shows that NIS mRNA was detected in the fetal
thyroid and in the fetal side of the placenta but was neither
found in fetal brain, brown adipose tissue (BAT), liver, heart,
and skin nor in the maternal side of the placenta during
MIDI. This was also the case during MID and MIDP (data
not shown). Figure 4 shows the changes in NIS expression in
response to iodine deficiency. In the fetal thyroid, NIS mRNA
level was already increased about 2-fold in MID, and in-
creased 3- to 4-fold in MIDP (Fig. 4). NIS mRNA was hardly
detected in the fetal side of the placenta in MIDI, but was
strongly induced in MID and MIDP (Fig. 5). Noteworthy,
these changes were not observed in the maternal side of the
placenta (basal layer).
We analyzed the expression of several other genes in the
fetal thyroid (Fig. 6). Tg mRNA content was similar in MIDI
and MID and increased 2-fold in MIDP. D1 mRNA did not
change in MID but increased about 2-fold in MIDP (Fig. 6).
On the contrary, Glut4 mRNA decreased in both MID and
MIDP, whereas Glut 1 mRNA content was similar in the
three groups.
Discussion
Plasma T4, T3, and TSH levels of the control rats (MIDI)
are comparable with those of rats on commercial pellet diet
and with those of rats receiving potassium iodide (10 mg/
liter) in their drinking water (24). Using the AIN diet without
adding extra I, we induced a mild iodine deficiency with
lowered T4 and normal T3 and TSH levels. It can be deduced
from urinary iodide excretion measurements in MID, that
rats received some I, probably from casein present in the AIN
diet (17), but also from the metabolism of their own thyroid
hormones. This degree of iodine deficiency can be compared
with that occurring in large parts of the world, where goiter
exists due to the low iodide intake, often aggravated by the
interference of other nutritional and/or environmental fac-
tors acting on the iodide uptake, organification, and/or thy-
roid hormone secretion processes (38).
The diet supplemented with 0.005% perchlorate (MIDP)
resulted in moderately severe iodine deficiency, with very
low plasma T4, high TSH, but still normal T3 levels not only
in rat dams, but also in their fetuses. The normal T3 levels in
moderately iodine-deficient adult rats has long been known
(16–24). How can the fetus maintain normal T3 levels in mild
FIG. 2. AIU (ng/24 h) of maternal and fetal thyroids and maternal
and fetal PII concentration (ng/ml). Fetal thyroids and plasma of the
fetuses were pooled per dam. Values are mean  SEM (n  6/group).
*, P  0.05 vs. MIDI.
FIG. 3. Northern blot analysis of NIS mRNA content of fetal organs.
Ribosomal 18S RNA is shown to correct for differences in total RNA
input, as cyclophilin expression is variable in the different tissues
examined. F, Fetal placenta; M, maternal or basal layer of the pla-
centa.
FIG. 4. NIS mRNA content of fetal thyroids at 21 d of gestation from
iodine-sufficient (MIDI) and iodine-deficient (MID and MIDP)
dams. Hybridization with cyclophilin (Cy) is shown to correct for
differences in total RNA input.
FIG. 5. Evidence for an induction of NIS gene expression in the fetal
side of the placenta at 21 d of gestation of MIDI, MID, and MIDP
rats. Northern blot analyses were performed on 15 g total RNA
extracted from the fetal and maternal sides of the placenta. Hybrid-
ization with cyclophilin (Cy) is shown to correct for differences in RNA
input.
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and moderately severe iodine-deficient conditions, consid-
ering that the maternal supply of T4 is so much lower than
in the normal situation, and that the maternal to fetal transfer
of T3 is expected to be insufficient to ensure normal fetal
plasma T3 (31)? This is not related to an increased flux of
iodide from the mother to the fetus because the PII of both
dams and fetuses are decreased in MID. Apparently, the
increase in NIS mRNA expression in the fetal placenta is not
sufficient to increase or normalize the fetal PII. In the ma-
ternal placenta, NIS mRNA seems not to be present, not even
in the iodine-deficient situation; it is still possible that the
maternal placenta is rate-limiting for iodide transport, or that
in the maternal placenta another transport system is present
(i.e. ion channels, which are not increased during iodine
deficiency). But also an adequate supply of T4 to the maternal
placenta might provide a means of transporting maternal
iodine stores to the fetus for fetal thyroid hormone synthesis
due to a difference in PII of the mother compared with that
of the fetus (39). The AIU of the fetal thyroid is only the
amount of iodide derived from the inorganic iodide pool of
the maternal circulation. The amount of iodide produced by
type II and type III deiodinase (D2 and D3) activity in the
placenta that partly is taken up by the fetal thyroid cannot be
measured. Thus, the measured fetal AIU is an underestima-
tion of the real total iodide uptake. By using the specific
activity of the iodide in the amniotic fluid, an AIU of 404
ng/24 h for MIDI and 154 ng/24 h for MID was obtained,
indeed, much higher than the fetal AIU in Fig. 2. This seems
unlikely, due to the fact that the total iodide content of the
fetal thyroid at d 21 is about 60–80 ng per total gland (23).
However, the decrease in MID compared with MIDI is
similar (as a percentage) in both calculations.
We bring evidence for a clear increase in NIS expression
in MID, and this increase occurs without significant increase
in TSH at that moment. We think that the order of events is:
when the intake of iodide is lowered, the PII is lower, re-
sulting in a decreased AIU. It takes some time before T4 is
lowered, but when that happens TSH increases transiently
and, thus, NIS will increase; AIU will increase, leading to an
increase in mainly T3 synthesis, but still a lowered T4. How-
ever, from this and earlier studies from our group, the up-
regulation of NIS expression does not seem to be sufficient
by itself to increase the AIU in the fetal thyroid, the values
are even lower (25). An increase in NIS mRNA does not only
reflect the change in the AIU. The AIU can also be influenced
by changes in pendrin and thyroid peroxidase. It is possible
that when pendrin and thyroid peroxidase (not measured)
would also increase, the organification will increase, and
thus there will be an increased retention of thyroidal iodide.
This can be the case for the mother in MID but not for the
fetus, because there the AIU is decreased.
Data from another experiment (similar iodide intake/level
and same plasma T4, T3, and TSH concentrations) showed
that NIS expression in the maternal thyroid increased about
3-fold in MID and about 5-fold in MIDP. The fetal thyroid
has to compete with the maternal thyroid and loses this
competition. Due to a higher increase in NIS expression in the
maternal thyroid, together with the higher amount of tissue
of the maternal thyroid compared with that of the fetuses,
this leads to an unchanged AIU and a lowered fetal AIU. As
in the adult, Glut4 is present in the fetal thyroid (40). A
putative thyroid hormone response element within the rat
Glut4 promoter was defined in skeletal muscle (41). Glut4 in
heart and BAT are under control of thyroid hormone (42). We
can hypothesize that Glut4 also in the thyroid is regulated by
thyroid hormone like D1 expression, which is stimulated by
T3 mediated by a thyroid hormone response element in the
D1 promoter. Yet, D1 expression is increased in hypothy-
roidism and decreased in hyperthyroidism because of the
overriding stimulatory effect of TSH. This may also apply to
genes such as Glut4. Thus, D1 and Glut4 are decreased in
MID (compared with MIDI) and increased in MIDP
(compared with MID). Because the process of the AIU is
energy dependent it can be suggested that the basal intra-
cellular energy (glucose) availability is diminished as indi-
cated by a decreased Glut4 mRNA expression.
As the adult thyroid, the fetal thyroid can preferentially
synthesize T3 (16–23). This was demonstrated in fetuses from
18–21 d of gestation, obtained from dams receiving low
iodine diets (23). The T3/T4 ratio in Tg extracted from the
thyroid of fetuses obtained from iodine-deficient dams was
3- to 4-fold higher than that measured in the fetal thyroid
obtained from iodine-sufficient mothers. A preferential T3
secretion by the fetal thyroid could also participate to normal
plasma T3 levels in the fetuses. As in the thyroid of adult rats
(17, 19) the free T3/T4 ratio was found elevated (5- to 8-fold)
in the thyroid of rat neonates (23). A possible preferential T3
FIG. 6. Northern blot analyses of the Tg, D1, and glucose transport-
ers (Glut 1 and 4) mRNA contents of the fetal thyroids at 21 d of
gestation. Each lane was loaded with 15 g total RNA extracted from
the thyroids of fetuses obtained from control (MIDI) and iodine-
deficient (MID and MIDP) dams. Hybridization with cyclophilin is
shown to correct for differences in RNA input.
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secretion is supported by the observed increased D1 expres-
sion, induced by increased TSH that could lead to an in-
creased T4 to T3 conversion as already reported in the adult
rat (43).
An increase in T3 production by peripheral D2 in extra-
thyroidal tissues might also contribute to normal T3 concen-
trations in the fetus. In tissues known for local T3 production,
there is an increase in D2 activity [brain (23), BAT (36),
placenta (24, 44–46)]. In the fetus, the skin is very active in
converting T4 to T3 and has high D2 activity (24).
In conclusion, all adaptive and/or defending mechanisms
against effects of iodine deficiency are already present in the
fetus. This means that each of the important steps in the
thyroid hormone economy, iodide uptake through an in-
creased expression of NIS, iodide organification, thyroid hor-
mone synthesis, secretion and peripheral bioactivation is
activated to work toward the delivery of sufficient amounts
of T3 to fetal tissues when iodide supply is limited.
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